Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant-MedSci.cn

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant

Edara, VV; Norwood, C; Floyd, K; Lai, LL; Davis-Gardner, ME; Hudson, WH; Mantus, G; Nyhoff, LE; Adelman, MW; Fineman, R; Patel, S; Byram, R; Gomes, DN; Michael, G; Abdullahi, H; Beydoun, N; Panganiban, B; McNair, N; Hellmeister, K; Pitts, J; Winters, J; Kleinhenz, J; Usher, J; O'Keefe, JB; Piantadosi, A; Waggoner, JJ; Babiker, A; Stephens, DS; Anderson, EJ; Edupuganti, S; Rouphael, N; Ahmed, R; Wrammert, J; Suthar, MS

Wrammert, J; Suthar, MS (corresponding author), Emory Univ, Dept Pediat, Ctr Childhood Infect & Vaccines Childrens Healthc, Sch Med, Atlanta, GA 30322 USA.; Wrammert, J; Suthar, MS (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Suthar, MS (corresponding author), Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.

Abstract

The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising concerns about the efficacy of infection- or vaccine-induced antib......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant

科室

工具

服务